Trials / Conditions / Invasive Lobular Breast Carcinoma

Invasive Lobular Breast Carcinoma

11 registered clinical trials studyying Invasive Lobular Breast Carcinoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications NCT07432633	Blue Earth Diagnostics	Phase 1 / Phase 2
Completed	Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System NCT06133647	Methodist Health System	—
Active Not Recruiting	Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the NCT04551495	Jules Bordet Institute	Phase 2
Terminated	[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma NCT04252859	University of Utah	Phase 2
Unknown	Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer NCT04021069	Sunnybrook Health Sciences Centre	—
Active Not Recruiting	Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing NCT01953588	Alliance for Clinical Trials in Oncology	Phase 3
Completed	Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy NCT01819233	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	N/A
Unknown	"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Ca NCT01641406	Auxilio Mutuo Cancer Center	Phase 2
Completed	Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer NCT01417286	Rutgers, The State University of New Jersey	Phase 2
Withdrawn	Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer NCT01100489	Case Comprehensive Cancer Center	Phase 2
Completed	Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer NCT01706432	University of Chicago	—